Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior government-funding and operating-status notice (Revision: v3.4.1) from the page.SummaryDifference0.6%

- Check21 days agoChange DetectedA government funding notice banner was added and the revision history was updated to v3.4.1, replacing the prior v3.4.0 entry.SummaryDifference0.6%

- Check28 days agoChange DetectedThe page now shows a glossary toggle and color-coded highlights for additions (green) and deletions (red) in the history view. The revision label was updated from v3.3.4 to v3.4.0.SummaryDifference0.8%

- Check64 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedOutcome Measures, Study Status, and Recruitment Status were added to the record history, and the previous 'Active, not recruiting' status was removed, with a new 'Completed' status recorded on 2025-12-11.SummaryDifference0.6%

- Check85 days agoChange DetectedThe history now shows Revision: v3.3.2 and removal of Revision: v3.3.1, an administrative update to the version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.